CareLit · DOI-Nachweis · Pneumologie
Effects of aclidinium bromide/formoterol fumarate fixed-dose combination on health status in COPD
DOI 10.1055/s-0035-1544636
Bibliografische Angaben
Nachweis in CareLit
Autor:innenPW Jones, S Korn, PD Scanlon, D Singh, V Mergel, E Molins, A Leselbaum
ZeitschriftPneumologie
Ausgabe02/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Aclidinium/formoterol fixed-dose combination (FDC) is in development for the treatment of COPD. We investigated the effect of the FDC on the health status of patients with moderate-to-severe COPD. Methods: ACLIFORM and AUGMENT were 24-week, randomized, double-blind Phase III studies of twice-daily FDC. Patients received placebo, aclidinium 400 µg, formoterol 12 µg, FDC 400/6 µg, or FDC 400/12 µg. Endpoin…
Zitieren
Zitierempfehlung
PW Jones, S Korn, PD Scanlon, D Singh, V Mergel, E Molins, A Leselbaum (2015) Effects of aclidinium bromide/formoterol fumarate fixed-dose combination on health status in COPD. Pneumologie (02). https://doi.org/10.1055/s-0035-1544636
Mit CareLit weiterarbeiten